ASPEN PHARMACARE HOLDINGS LIMITED - Further Update to Aspen Shareholders

Further Update to Aspen Shareholders

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) (“Aspen Holdings”)
Registration number: 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
and its subsidiaries (collectively “Aspen” or “the Group”)


FURTHER UPDATE TO ASPEN SHAREHOLDERS - DIVESTMENT OF ASPEN’S NUTRITIONALS BUSINESS TO
LACTALIS –UNCONDITIONAL CLOSURE OF TRANSACTION

With reference to previous announcements in respect of the Group’s divestment of its Nutritionals
Business to the Lactalis Group, Aspen is pleased to confirm that there are no remaining conditions
precedent which require fulfilment and that the transaction has been confirmed for unconditional closure
on 31 May 2019, with gross proceeds of EUR 740 million due to flow to Aspen on that date.



Sponsor
Investec Bank Limited



Durban
29 May 2019

Sponsor:
Investec Bank Limited

Date: 29/05/2019 09:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.